Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lord

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Transplantation Proceedings|April 1, 1988
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allograftsR H Lord, W M Padberg, R Di Stefano, et al.
Substance Use & Misuse|December 22, 2007
Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sampleDarrell R Christian, Alice Huber, Mary-Lynn Brecht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancementW M Padberg, R H Lord, J W Kupiec-Weglinski, et al.
Human Brain Mapping|October 29, 2018
The impact of type 1 diabetes on neural activity serving attentionChristine M Embury, Alex I Wiesman, Timothy J McDermott, et al.
Diabetes|March 14, 2018
Altered Brain Dynamics in Patients With Type 1 Diabetes During Working Memory ProcessingChristine M Embury, Alex I Wiesman, Amy L Proskovec, et al.
Journal of Medical Genetics|October 15, 2016
Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the <i>ERF</i> geneM Balasubramanian, H Lord, S Levesque, et al.
ESMO Open|April 10, 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancerM Stares, T E Ding, C Stratton, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Transplantation Proceedings|April 1, 1988
Immunohistologic profile of cells infiltrating acutely rejecting and long-surviving rat cardiac allograftsR H Lord, W M Padberg, R Di Stefano, et al.
Substance Use & Misuse|December 22, 2007
Methamphetamine users entering treatment: characteristics of the methamphetamine treatment project sampleDarrell R Christian, Alice Huber, Mary-Lynn Brecht, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 15, 1987
Two phenotypically distinct populations of T cells have suppressor capabilities simultaneously in the maintenance phase of immunologic enhancementW M Padberg, R H Lord, J W Kupiec-Weglinski, et al.
Human Brain Mapping|October 29, 2018
The impact of type 1 diabetes on neural activity serving attentionChristine M Embury, Alex I Wiesman, Timothy J McDermott, et al.
Diabetes|March 14, 2018
Altered Brain Dynamics in Patients With Type 1 Diabetes During Working Memory ProcessingChristine M Embury, Alex I Wiesman, Amy L Proskovec, et al.
Journal of Medical Genetics|October 15, 2016
Chitayat syndrome: hyperphalangism, characteristic facies, hallux valgus and bronchomalacia results from a recurrent c.266A>G p.(Tyr89Cys) variant in the <i>ERF</i> geneM Balasubramanian, H Lord, S Levesque, et al.
ESMO Open|April 10, 2022
Biomarkers of systemic inflammation predict survival with first-line immune checkpoint inhibitors in non-small-cell lung cancerM Stares, T E Ding, C Stratton, et al.
Pageof 10